Is the drug industry spending millions on a made-up disease? Have the latest cancer drugs been overhyped? And why does anyone go to BIO?
We discuss all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Tune in for a discussion of NASH, the purported billion-dollar market opportunity that might be too good to be true, followed by a breakdown of a pair of upcoming conferences — one packed with news and the other not so much. Then comes a lightning round that touches on President Trump’s vague promises, the mystery surrounding a genomics pioneer, and drugs that make you racist.